CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
about
Pathogenesis of human immunodeficiency virus infectionT helper cell activation and human retroviral pathogenesisRetroviral superinfection resistance.Current concepts in human immunodeficiency virus infection and AIDSFactors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression.Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.Inhibition of simian immunodeficiency virus (SIV) replication by CD8(+) T lymphocytes from macaques immunized with live attenuated SIVStudy of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus.CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.Human immunodeficiency virus and AIDS: insights from animal lentivirusesPurified bovine plasma blocking factor decreases Bovine leukemia virus p24 expression while increasing protein synthesis and transcriptional activity of peripheral blood mononuclear cells in short-term cultureAltered representation of naive and memory CD8 T cell subsets in HIV-infected children.Cellular immune responses to HIV.Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infectionSuppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression.The role of immunity in protection from mucosal SIV infection in macaques.Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytesInhibition of human immunodeficiency virus type 1 infection of human CD4+ T cells by microbial HSP70 and the peptide epitope 407-426Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virusSusceptibility of nude mice carrying the Fv-4 gene to Friend murine leukemia virus infection.Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanismsHuman immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract.Therapeutic role of CD8+ T cells in HIV-1 infection: targets and suppressors of viral replication.Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates.Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8+ T cells.Initiation of human immunodeficiency virus type 1 (HIV-1) transcription is inhibited by noncytolytic CD8 suppressionInduction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.Enhancing of anti-viral activity against HIV-1 by stimulation of CD8+ T cells with thymic peptides.Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women.HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replicationPeripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load.Analysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.Long-term survivors of HIV infection.Inhibitory effect of 3'-azido-3'-deoxythymidine on proliferative responsiveness of CD8+ lymphocytes to interleukin-2.
P2860
Q24634681-006D0B27-A64D-42DC-B59D-BF51A96B3532Q24650854-0D190EC1-14D6-4E61-BF51-85843C6CF56DQ24815564-E5C96BD9-D68A-4356-8295-AE221BCCC6FDQ33606809-C20E267B-022F-4654-9A2F-347EAE05A312Q33649657-8423727D-2246-4D87-A199-26B9A5FE567EQ33747965-BAD0C031-BB61-4DAB-A414-606F4353E562Q33759097-2FD1B7AC-AE52-492A-BE81-B493181C1261Q33783155-44FE09E1-937B-4C4F-AF63-E067257C6C16Q33786049-ADA49119-1AB4-4332-A89F-606429406D04Q33786386-DF763AE4-E2C1-4207-9BC3-5A3454B300D4Q33804193-853F52E3-78FD-44DB-A188-ED123D710D91Q33809273-F8E3A298-6DDD-4866-9DAB-8DE11C2CFCA3Q33899277-E4D736A8-C077-482C-BF70-10C485DA7578Q34215632-39322E43-272F-46DE-B70C-F2A06803B1A4Q34223069-C371AB24-BE1B-4BED-8EB0-9DB04969D6C8Q34335966-2F9A8658-EEDA-4698-9E86-8DCBE7BB17D1Q34593086-3AEEF083-7DA9-4193-9314-C92A541C8B8CQ34658462-0EE3B6C2-2B1C-42B3-A618-A30825F5EC8EQ34775270-44328ED2-8895-40C2-BA7D-33EE9A762AC6Q35224252-9F5F65DC-F545-492D-9232-651CAA799677Q35785019-2BA9E9C0-9276-4121-AF0F-92BAD865E5C0Q35859063-F02B0FDB-DCF7-4DBC-981B-A28469E72E9EQ35875914-D31E306D-6FD5-4241-BC38-E0E90B04FEC2Q35881271-D21403D0-9224-4C78-869B-4BB526798D35Q35882457-959C4C2A-9C65-4A3F-8E02-5E0F75DA936FQ36099451-4C84BAFA-6C20-4880-AD11-C44240DC0CACQ36598618-12776162-185E-4362-B796-6CF4713BDAF1Q36688376-5A62C801-17E3-480B-9A23-08255B1BF000Q37094738-3453AE29-441C-4C7B-8864-66B159ECCBFEQ37157103-D5CAE789-0AED-4263-AB49-8010ACE11EBDQ37175151-8C4AA3DA-6A13-416B-9977-EE1895E1E54AQ37375957-207466E3-3175-4D89-8335-6ED42ACB3E70Q37638811-25A2C2F7-6F94-4C7E-862F-443FC4B0C397Q39287711-25C5B6F3-00C8-4291-94C5-A405ADC25CFFQ39577265-D0390A7D-99AC-49FB-BFE2-43CC54F60F4AQ39583378-39FE620F-C616-49EE-B940-CE97097653ACQ39699806-28D8AF33-DB33-429F-970B-662F3CB665FDQ40111950-2B8C941A-E355-439A-9ECF-A7AA1DA19EFFQ40634258-218E649C-4731-4010-80B7-2056C6A0B6FDQ40672667-0A83B024-9798-4193-9990-1CF6661862ED
P2860
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
@ast
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
@en
type
label
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
@ast
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
@en
prefLabel
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
@ast
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
@en
P356
P1476
CD8+ cell anti-HIV activity: nonlytic suppression of virus replication.
@en
P2093
P304
P356
10.1089/AID.1992.8.1039
P577
1992-06-01T00:00:00Z